Astragaloside IV has been shown to have a renoprotective effect on relieving renal fibrosis and renal function in diabetic mice, and effects on podocyte EMT by regulating the SIRT1-NF-κB pathway and autophagy (Wang et al., 2019c). The gene discussed is NFKB1; the disease is renal fibrosis.